CervoMed Inc. Deferred Income Tax Expense (Benefit)
CervoMed Inc. (CRVO) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2023-03-24
- CervoMed Inc. deferred income tax expense (benefit) for the quarter ending 2022-12-31 was $0.00.
- CervoMed Inc. deferred income tax expense (benefit) for the quarter ending 2021-12-31 was $0.00.
- CervoMed Inc. deferred income tax expense (benefit) for the quarter ending 2021-09-30 was -$443.89K.
- CervoMed Inc. deferred income tax expense (benefit) for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. deferred income tax expense (benefit) for fiscal 2022 was $0.00.
- CervoMed Inc. deferred income tax expense (benefit) for fiscal 2021 was -$443.89K.
- CervoMed Inc. deferred income tax expense (benefit) for fiscal 2020 was -$1.68M, a 603.29% decline from fiscal 2019.
- CervoMed Inc. deferred income tax expense (benefit) for fiscal 2019 was $332.88K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $0.00 10-K · filed 2023-03-24 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | -$443.89K derived: sum of 2 quarters · filed 2023-03-24 | -$443.89K 10-K · filed 2023-03-24 | |
| 2021-09-30 | -$443.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$443.89K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-11 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$805.68K derived: sum of 2 quarters · filed 2022-03-18 | -$1.31M derived: sum of 3 quarters · filed 2022-03-18 | -$1.68M 10-K · filed 2022-03-18 |
| 2020-09-30 | -$805.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$1.31M derived: sum of 2 quarters · filed 2021-11-10 | -$1.68M 10-Q · filed 2021-11-10 | -$857.28K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$507.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$869.71K 10-Q · filed 2021-08-11 | -$51.60K derived: sum of 3 quarters · filed 2021-08-11 | -$277.56K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$362.38K 10-Q · filed 2021-05-07 | $455.72K derived: sum of 2 quarters · filed 2021-05-07 | $229.76K derived: sum of 3 quarters · filed 2021-05-07 | $120.86K derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $818.10K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $592.14K derived: sum of 2 quarters · filed 2021-03-17 | $483.24K derived: sum of 3 quarters · filed 2021-03-17 | $332.88K 10-K · filed 2021-03-17 |
| 2019-09-30 | -$225.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$334.86K derived: sum of 2 quarters · filed 2020-11-12 | -$485.22K 10-Q · filed 2020-11-12 | -$440.08K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$108.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$259.26K 10-Q · filed 2020-08-07 | -$214.12K derived: sum of 3 quarters · filed 2020-08-07 | -$428.61K derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | -$150.35K 10-Q · filed 2020-05-11 | -$105.22K derived: sum of 2 quarters · filed 2020-05-11 | -$319.71K derived: sum of 3 quarters · filed 2020-05-11 | |
| 2018-12-31 | $45.14K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -$169.36K derived: sum of 2 quarters · filed 2020-03-17 | -$437.29K 10-K · filed 2020-03-17 | |
| 2018-09-30 | -$214.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$482.43K 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | -$267.93K 10-Q · filed 2019-08-08 | |||
| 2017-12-31 | -$1.06M 10-K · filed 2019-03-19 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$364.80K 10-K · filed 2018-04-02 | ||
| 2016-09-30 | -$364.80K 10-Q · filed 2017-11-13 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-03-31 | |||
| 2014-12-31 | -$2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$2.58M derived: sum of 2 quarters · filed 2016-03-25 | -$2.82M 10-K · filed 2016-03-25 | |
| 2014-09-30 | -$146.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$384.13K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | -$238.13K 10-Q · filed 2015-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |